Oppenheimer & Co’s BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. DCF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-19,085
Closed -$145K 1507
2023
Q1
$145K Hold
19,085
﹤0.01% 1300
2022
Q4
$135K Hold
19,085
﹤0.01% 1270
2022
Q3
$130K Buy
19,085
+2,905
+18% +$21.4K ﹤0.01% 1274
2022
Q2
$119K Buy
+16,180
New +$129K ﹤0.01% 1325
2021
Q2
Sell
-19,722
Closed -$185K 1589
2021
Q1
$185K Buy
19,722
+4,300
+28% +$38.6K ﹤0.01% 1357
2020
Q4
$131K Buy
15,422
+2,227
+17% +$18.1K ﹤0.01% 1294
2020
Q3
$106K Buy
13,195
+3,100
+31% +$24.9K ﹤0.01% 1229
2020
Q2
$77K Buy
+10,095
New +$72.7K ﹤0.01% 1218

Other funds holding DCF

Oppenheimer & Co's DCF Position: Q2 2023 in Review

Oppenheimer & Co sold out of BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. (DCF) in Q2 2023, closing a stake of 19,085 shares — an estimated $145K sold.

Oppenheimer & Co first reported a position in DCF in Q2 2020 and held it in 8 quarters. The position peaked at $185K in Q1 2021. 27 funds tracked by Wall St. Rank hold DCF as of Q2 2023.

  • Oppenheimer & Co reported no remaining BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. position as of Q2 2023 after selling out during the quarter.
  • Oppenheimer & Co sold 19,085 BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. shares in Q2 2023, an estimated $145K.
  • Oppenheimer & Co first reported a position in BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. in Q2 2020 and held it in 8 quarters.
  • Oppenheimer & Co's BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. position peaked at $185K in Q1 2021.
  • 27 funds tracked by Wall St. Rank held BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. as of Q2 2023.

Based on Oppenheimer & Co's 13F filing for Q2 2023, filed 3 Aug 2023.